Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Papillomavirus Infections. Found 9 abstracts

Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet (London, England). 2019 Jan 05;393(10166):40-50.   PMCID: PMC6541928
Liederbach E, Kyrillos A, Wang CH, Liu JC, Sturgis EM, Bhayani MK. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma. International journal of cancer. 2017 Feb;140(3):504-12.
Beitler JJ, Quon H, Jones CU, Salama JK, Busse PM, Cooper JS, Koyfman SA, Ridge JA, Saba NF, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS, Expert Panel on Radiation Oncology H, Neck. ACR Appropriateness Criteria((R)) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Head & neck. 2016 Sep;38(9):1299-309.
Capo-chichi CD, Aguida B, Chabi NW, Cai QK, Offrin G, Agossou VK, Sanni A, Xu XX. Lamin A/C deficiency is an independent risk factor for cervical cancer. Cellular oncology (Dordrecht). 2016 Feb;39(1):59-68.
Bhatia A, Burtness B. Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials. J Clin Oncol. 2015 Oct 10;33(29):3243-50.   PMCID: PMC5814107
Isayeva T, Xu J, Ragin C, Dai Q, Cooper T, Carroll W, Dayan D, Vered M, Wenig B, Rosenthal E, Grizzle W, Anderson J, Willey CD, Yang ES, Brandwein-Gensler M. The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways. Mod Pathol. 2015 May;28(5):631-53.
Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang D, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Head & neck. 2014 Dec;36(12):1677-84.   PMCID: PMC3972378
Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. J Gastrointest Cancer. 2013 Dec;44(4):450-5.   PMCID: Pmc3963822
Gorin SS, Wang C, Raich P, Bowen DJ, Hay J. Decision making in cancer primary prevention and chemoprevention. Ann Behav Med. 2006 Dec;32(3):179-87.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Papillomavirus Infections

Papillomavirus Infections Female pathology virology Middle Aged Male Squamous Cell Carcinoma metabolism therapy Head and Neck Neoplasms Prognosis methods Oropharyngeal Neoplasms Neoplasm Invasiveness Risk Factors Aged Oropharynx pathogenicity epidemiology Chemoradiotherapy Age Factors Survival Analysis Western Blotting Tumor Cell Line Immunohistochemistry Follow-Up Studies Neoplasm Staging therapeutic use complications Squamous Cell Carcinoma of Head and Neck mortality Papillomaviridae human papillomavirus (HPV) diagnosis genetics administration & dosage Local Neoplasm Recurrence Neoplasm Proteins Adult Lamin A Treatment Outcome Cervical Intraepithelial Neoplasia Viral DNA extracapsular extension (ECE) unknown primary analysis Combined Modality Therapy concurrent chemotherapy Unknown Primary Neoplasms Neoplasms Pharyngectomy adverse effects Cell Nucleus Practice Guidelines as Topic Papillomavirus Vaccines Chemoprevention Tamoxifen human papillomavirus Case-Control Studies Antineoplastic Agents Kaplan-Meier Estimate oropharynx Cervical neoplasia HIV Seropositivity National Cancer Data Base Mouth Neoplasms Transfection Colposcopy Anus Neoplasms Cervical cancer prevention Uterine Cervical Neoplasms C deficiency Immunoenzyme Techniques Cyclin-Dependent Kinase Inhibitor p16 Real-Time Polymerase Chain Reaction Cetuximab base of tongue cancer Oncogenic HPV HIV tissue microarray Continental Population Groups Delphi Technique surgery oropharyngeal cancer head and neck cancer Forecasting 80 and over Aged Cisplatin Biological Tumor Markers Disease-Free Survival Tissue Array Analysis Breast Neoplasms Vaginal Smears Survival Rate transoral robotic surgery (TORS) Clinical Trials as Topic tonsillar cancer Risk Assessment Medical Societies Hormone Replacement Therapy Cell Nucleus Shape Neck Dissection Incidence Tumor Biomarkers isolation & purification prevention & control Decision Making deficiency Young Adult Fluorescent Antibody Technique Drug Administration Schedule squamous cell carcinoma Lamin Type A Reverse Transcriptase Polymerase Chain Reaction Intensity-Modulated Radiotherapy Primary Prevention Prevalence biosynthesis
Last updated on Friday, December 06, 2019